{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:03:15Z","timestamp":1790708595671,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.neulet.2012.08.069","type":"journal-article","created":{"date-parts":[[2012,9,7]],"date-time":"2012-09-07T16:30:13Z","timestamp":1347035413000},"page":"205-209","source":"Crossref","is-referenced-by-count":26,"title":["Increased dimerization of alpha-synuclein in erythrocytes in Gaucher disease and aging"],"prefix":"10.1016","volume":"528","author":[{"given":"Assimina","family":"Argyriou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Dermentzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Themistoklis","family":"Papasilekas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Moraitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Stamboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Vekrellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Michelakakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Stefanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2012.08.069_bib0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jbspin.2007.06.006","article-title":"Red blood cells are the major source of alpha-synuclein in blood","volume":"5","author":"Barbour","year":"2008","journal-title":"Neurodegenerative Diseases"},{"key":"10.1016\/j.neulet.2012.08.069_bib0010","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s10545-010-9055-0","article-title":"Lymphomonocyte alpha-synuclein levels in aging and in Parkinson disease","volume":"31","author":"Brighina","year":"2010","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.neulet.2012.08.069_bib0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/brain\/awp044","article-title":"The risk of Parkinson's disease in type 1 Gaucher disease","volume":"33","author":"Bultron","year":"2010","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1016\/j.neulet.2012.08.069_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMoa0901281","article-title":"Free radical metabolism in human erythrocytes","volume":"390","author":"Cimen","year":"2008","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.neulet.2012.08.069_bib0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/mds.22538","article-title":"The glycosphingolipids of human plasma lipoproteins","volume":"59","author":"Clarke","year":"1981","journal-title":"Canadian Journal of Biochemistry"},{"key":"10.1016\/j.neulet.2012.08.069_bib0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.expneurol.2007.05.022","article-title":"Cell systems and the toxic mechanism(s) of alpha-synuclein","volume":"209","author":"Cookson","year":"2008","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.neulet.2012.08.069_bib0035","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1212\/01.wnl.0000230215.41296.18","article-title":"Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha synuclein processing","volume":"69","author":"Cullen","year":"2011","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.neulet.2012.08.069_bib0040","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1159\/000112832","article-title":"The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism","volume":"24","author":"DePaolo","year":"2009","journal-title":"Movement Disorders"},{"key":"10.1016\/j.neulet.2012.08.069_bib0045","doi-asserted-by":"crossref","first-page":"24515","DOI":"10.1016\/j.neurobiolaging.2008.06.010","article-title":"Glycosphingolipid accumulation inhibits cholesterol efflux via the ABCA1\/apolipoprotein A-I pathway: 1-phenyl-2-decanoylamino-3-morpholino-1-propanol is a novel cholesterol efflux accelerator","volume":"280","author":"Glaros","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.neulet.2012.08.069_bib0050","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuro.2009.06.009","article-title":"Glucocerebrosidase mutations are an important risk factor for Lewy body disorders","volume":"67","author":"Goker-Alpan","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2012.08.069_bib0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2010.12.014","article-title":"Gaucher disease","volume":"75","author":"Guggenbuhl","year":"2008","journal-title":"Joint, Bone, Spine"},{"key":"10.1016\/j.neulet.2012.08.069_bib0060","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ana.22400","article-title":"Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease alpha-synuclein fibrillogenesis","volume":"42","author":"Krishnan","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.neulet.2012.08.069_bib0065","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Alpha-synuclein glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism","volume":"30","author":"Manning-Bo\u011f","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neulet.2012.08.069_bib0070","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1021\/bi026528t","article-title":"Brain cholesterol in normal and pathological aging","volume":"1801","author":"Martin","year":"2010","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.neulet.2012.08.069_bib0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1074\/jbc.M413862200","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2012.08.069_bib0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1399-0004.1982.tb01445.x","article-title":"Plasmalogen levels in Gaucher disease","volume":"41","author":"Moraitou","year":"2008","journal-title":"Blood Cells, Molecules, and Diseases"},{"key":"10.1016\/j.neulet.2012.08.069_bib0085","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1139\/o81-057","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2012.08.069_bib0090","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bbalip.2010.03.011","article-title":"Increased cerebroside concentration in plasma and erythrocytes in Gaucher disease: significant differences between type I and type III","volume":"22","author":"Nilsson","year":"1982","journal-title":"Clinical Genetics"},{"key":"10.1016\/j.neulet.2012.08.069_bib0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease","volume":"477","author":"Prigione","year":"2010","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neulet.2012.08.069_bib0100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1385\/MN:30:1:001","article-title":"The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2012.08.069_bib0105","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.cca.2007.12.025","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.neulet.2012.08.069_bib0110","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.bcmd.2008.03.007","article-title":"Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease","volume":"65","author":"Tokuda","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2012.08.069_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2010.04.022","article-title":"Neurobiology of alpha-synuclein","volume":"30","author":"Vekrellis","year":"2004","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.neulet.2012.08.069_bib0120","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1212\/WNL.0b013e3181fd613b","article-title":"Inducible over-expression of wild type alpha-synuclein in human neuronal cells leads to caspase-dependent nonapoptotic death","volume":"109","author":"Vekrellis","year":"2009","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.neulet.2012.08.069_bib0125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1471-4159.2009.06054.x","article-title":"Accumulation and distribution of alpha-synuclein and ubiquitin in the CNS of Gaucher disease mouse models","volume":"102","author":"Xu","year":"2011","journal-title":"Molecular Genetics and Metabolism"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394012011639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394012011639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:26:39Z","timestamp":1542759999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394012011639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0304394012011639"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2012.08.069","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}